Yasir Al-Wakeel announced as new Chief Financial Officer for Kronos Bio, Inc.
Kronos Bio, Inc. announced Yasir Al-Wakeel, BM BCh, as the company’s new Chief Financial Officer. Dr. Al-Wakeel began his career as a practicing physician, holding both clinical and academic medical posts in the United Kingdom before his roles in finance and early-stage biotechnology.
Kronos Bio is a clinical-stage biopharmaceutical company dedicated to the discovery and development of novel cancer therapeutics. The firm is headquartered in Massachusetts, United States.